Ask Warren

NeoImmuneTech

950220 · KOSDAQ · ₩950220 · 네오이뮨텍

₩1,576▼ ₩56 (3.43%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩788,200₩359,672₩27,007₩12,976₩17,579₩9,111−₩681,355₩806,272
Cost of sales−₩4.5M₩4.6M₩4.2M₩3.2M₩4.8M₩5.6M₩4.9M₩9.3M
Gross profit₩5.3M−₩4.2M−₩4.2M−₩3.2M−₩4.8M−₩5.6M−₩5.6M−₩8.5M
Operating income−₩2.8M−₩4.2M−₩4.2M−₩3.2M−₩4.8M−₩5.6M−₩5.6M−₩8.5M
Net income−₩300,744−₩5.2M−₩7.4M−₩4.1M−₩5.1M−₩5.7M−₩6.1M−₩7.9M
Net income to shareholders−₩300,744−₩5.2M−₩7.4M−₩4.1M−₩5.1M−₩5.7M−₩6.1M−₩7.9M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩49M₩52M₩57M₩63M₩36M₩40M₩45M₩55M
Current assets₩33M₩40M₩44M₩53M₩27M₩23M₩27M₩35M
Cash and equivalents₩23M₩23M₩27M₩41M₩15M₩19M₩23M₩29M
Total liabilities₩13M₩16M₩16M₩16M₩18M₩17M₩16M₩20M
Current liabilities₩12M₩15M₩14M₩15M₩17M₩16M₩14M₩8.4M
Borrowings₩5.7M₩5.4M₩5.3M₩6M₩5.9M₩5.1M₩4.7M₩15M
Total equity₩37M₩36M₩41M₩47M₩18M₩22M₩28M₩35M
Shareholders' equity₩37M₩36M₩41M₩47M₩18M₩22M₩28M₩35M

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩3.2M−₩3.8M−₩3.9M−₩4.7M−₩4.8M−₩4.1M−₩5M−₩8.9M
Capital spending−₩21₩1,649₩56,000——₩130,037₩732,748₩350,537
Free cash flow−₩3.2M−₩3.8M−₩4M−₩4.7M−₩4.8M−₩4.3M−₩5.8M−₩9.2M

Consolidated where available. Amounts in won.

Also known as: NeoImmuneTech / 네오이뮨텍 / 950220 / KRX:950220

Source: KRX statistical information